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This paper presents a method for introducing toluene and bromobenzene moieties into 1,2,4-
triazines as an alternative to cross-coupling reactions. It is demonstrated that the C=N bond of a wide
range of 1,2,4-triazines undergoes addition of arenes in the presence of AlCl3.
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Introduction
The structure of 1,2,4-triazines is analogous to
that of nucleobases, which encourages an ongoing
search of bioactive compounds among them. Re-
cent publications devoted to 5,6-biaryl derivatives
of 1,2,4-triazines describe them as potential adeno-
sine A2A receptor antagonists (anti-Parkinsonism) [1]
as well as neuroprotective [2, 3] and anti-tumor
agents [4, 5]. These substances are also known to in-
hibit thrombocyte aggregation [6] and to possess anti-
inflammatory [7 – 9], antidepressant [10], antibacte-
rial [11], herbicidal [11], fungicidal [11, 12], and pes-
ticidal [11, 13] properties.
A general synthetic pathway towards 1,2,4-triazines
3 involves condensation of 1,2-dicarbonyl compounds
1 with amidrazones 2 (Path A, Scheme 1) [14]. This
approach is very convenient for the synthesis of 1,2,4-
triazines bearing identical substituents at C(5) and
C(6). However, for 1,2,4-triazines with different sub-
stituents at these positions this method is challenging
due to the formation of mixtures of isomeric 1,2,4-
triazines from unsymmetrical 1,2-dicarbonyl com-
pounds (R1 6= R2) (Scheme 1) [15 – 18].
The current paper is devoted to the synthesis of 5,6-
diaryl derivatives of 1,2,4-triazines 3 with R1 6= R2
(Path B, Scheme 1). For this objective there are cur-
rently four possible starting triazine substrates avail-
able (Scheme 2). First, it is 1,2,4-triazine (6) with an
unsubstituted carbon atom. It is known that introduc-
tion of arenes with strong electron-donating groups
(e. g. phenols and anilines) into 1,2,4-triazines can
be achieved by activation of the latter with acids,
which leads to the formation of triazinium cations
and subsequent oxidation of the formed dihydro in-
termediates (route A, Scheme 2) [14, 19, 20]. How-
ever, no 5,6-biaryl derivatives have been synthesized
via this route. Increasing the reactivity of arenes by
conversion to Grignard reagents allows to perform
reactions with non-activated 1,2,4-triazines (route B,
Scheme 2) [21 – 24] and even 1,2,4-triazin-4-oxides 7
(route C, Scheme 2) [25]. It is also known that in
acidic media 1,2,4-triazin-4-oxides 7 can form adducts
with arenes bearing strongly electron-donating groups
(R=OR) (route D, Scheme 2) [26, 27]. The third
possible substrates for the synthesis of 3 are halo-
genated triazine derivatives 8. Studies of mono- and
diazahetarenes have demonstrated that the presence of
a halogen atom in an azine molecule (pyridine [28],
phthalazine [29], quinazoline [30], quinolines [30]) al-
lows to employ ipso-substitution reactions with arenes
bearing various electron-donating groups in the pres-
ence of AlCl3 (route E, Scheme 2), or to react the
arenes with the corresponding Grignard reagents (route
F, Scheme 2) [31]. Cross-coupling reactions allow to
introduce a wide range of aryl substituents into halo-
genated azines (route G, Scheme 2) [32, 33]. How-
ever, successful cross-coupling arylation (Suzuki reac-
tion) has been reported only for 6-bromo derivatives
(R=Cl, CH3, OH), at C(6) [1]. Another noteworthy
substrate for the target compounds 3 are 1,2,4-triazines
9 bearing a CCl3 group at C(3), that undergo tele-
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Scheme 1. Two pathways to the substituted 1,2,4-triazines.
Scheme 2 (color online). The routes for the introduction of aryl substituents into azaarenes.
substitution with OH-substituted arenes, leading to the
formation of triazines 3 (route H, Scheme 2) [34].
Among the described triazine precursors to aryl-
triazines 3, compounds 6 attract the highest inter-
est due to the easier availability of most unsubsti-
tuted triazines. Recently, the arylation of 1,3,5-triazin-
2,4(1H,2H)-dione, which is highly reactive towards
nucleophiles, has been reported. It was demonstrated
that this compound can add benzene and its derivatives
with various electron-donating groups (R=CH3, Cl,
Br, NMe2) in the presence of AlCl3 [35].
Results and Discussion
In the current study, AlCl3-mediated reactions of
arenes with a wide range of 1,2,4-triazines not bearing
any additional good leaving groups were investigated.
Most valuable are triazines bearing arene moieties with
substituents that allow further modification. Thus, the
possibility of introducing bromobenzene and toluene
fragments into 1,2,4-triazines was studied. Reactions
of arenes with 1,2,4-triazin-3(2H)-ones 10–13 and 5,6-
diphenyl-1,2,4-triazin-3(2H)-thione (14) proceed with
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Scheme 3.
the formation of arene adducts at C(5) position of the
triazine ring with 23 – 69% yields (Scheme 3, Table 1).
Reactions with bromobenzene are too slow at room
temperature, and that is why the temperature of boil-
ing bromobenzene was used. In most cases the reac-
tion conditions lead to the partial destruction of the tri-
azines under formation of complex mixtures of prod-
ucts.
Table 1. Synthesis of 5-aryl derivatives from 1,2,4-triazin-3(2H)-ones and 1,2,4-triazin-3(2H)-thiones.
Triazine R1 R2 X Ar T (◦C) Time (h) Product Yield (%)
10 Ph H O p-CH3Ph 25 18 15a 57
p-BrPh 156 1 – mixture of
products
11 p-CH3Ph H O p-CH3Ph 25 18 16a 66
p-BrPh 156 1 16b 44
12 p-BrPh H O p-CH3Ph 25 18 17a 63
p-BrPh 156 1 – mixture of
products
13 Ph Ph O p-CH3Ph 25 18 18a 69
p-BrPh 156 1 – no reaction
14 Ph Ph S p-CH3Ph 25 18 19a 23
p-BrPh 156 1 – decomposition
Scheme 4.
Table 2. Synthesis of 5-arylderivatives of 1,2,4-triazines.
Triazine R1 R2 R3 Ar T (◦C) Time (h) Product Yield (%)
20 H H SMe p-CH3Ph 25 1 26 23
p-BrPh 25 18 27 40
21 H H Ph p-CH3Ph 25 18 mixture
p-BrPh 25 18 28 47
22 H Ph CH3 p-CH3Ph 25 18 29 38
23 Ph Ph Ph p-CH3Ph 25 18 30 51
24 Ph Ph CH3 p-CH3Ph 25 18 31 61
25 p-CH3Ph H Ph p-CH3Ph 25 18 32 73
Studies of the reactions of triazines without C=O or
C=S groups with arenes have shown that this reaction
similarly leads generally to the formation of adducts at
C(5). The only difference was observed for the reaction
of 5,6-unsubstituted triazine 20 with toluene at room
temperature. An oxidized product 26 was obtained,
presumably due to the low stability of the formed
adduct to atmospheric oxygen. The triazine 20 is very
susceptible to nucleophiles, and after 18 hours of re-
action it was usually not possible to obtain products of
a nucleophilic addition because of decomposition reac-
tions (Scheme 4, Table 2). Compounds 22, 23 and 24
do not react with bromobenzene neither at 25 ◦C nor at
156 ◦C.
1,2,4-Triazines bearing an oxo group at posi-
tion C(5), such as 3-Ph-1,2,4-triazin-5(4H)-one,
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Scheme 5. The proposed mechanism for the arylation of 1,2,4-triazin-3(2H)-ones.
Scheme 6. The proposed mechanism for the arylation of 1,2,4-triazines.
6-Ph-1,2,4-triazin-5(4H)-one or 6-Ph-1,2,4-triazin-
3,5(2H,4H)-dione appeared not to be susceptible
to activation with aluminum chloride at ambient
temperature and at reflux in the corresponding arene.
Deaza analogs of 6-Ph-1,2,4-triazin-3(2H)-one,
5-Ph-pyrimidin-2(1H)-one and 1-Me-5-Ph-pyrimidin-
2(1H)-one, were also inert under the described
conditions.
In the presence of strong acids, the studied tri-
azines usually form triazinium cations, which can add
strong nucleophiles, such as indoles, anilines and phe-
nols [14, 19, 20]. It was demonstrated that activation
with CF3COOH is not sufficient to perform reactions
with toluene and bromobenzene. The suggestion is that
aluminum chloride in the studied process acts as a su-
peracid [36] which leads to the conversion of 1,2,4-
triazine to a dication [37 – 41] which is capable of
reacting with arenes with the formation of dihydro-
products (Schemes 5, 6).
Conclusion
In the current study a convenient method for the
activation of triazines with aluminum chloride is pre-
sented, which can afford 1,2,4-triazines with different
substituents at C(5) and C(6). This method is a viable
alternative to the existing ones, and a number of novel
1,2,4-triazines were obtained as a result of its applica-
tion.
Experimental Section
6-Ar-1,2,4-triazin-3(2H)-ones (10–12) [42], 5,6-
diphenyl-1,2,4-triazin-3(2H)-one (13) [43], 5,6-diphenyl-
1,2,4-triazine-3(2H)-thione (14) [44], 3-(methylthio)-
1,2,4-triazine (20) [45], 3-phenyl-1,2,4-triazine (21) [45],
3-methyl-5-phenyl-1,2,4-triazine (22) [17], 3,5,6-triphenyl-
1,2,4-triazine (23) [46], 3-methyl-5,6-diphenyl-1,2,4-triazine
(24) [46] and 3-phenyl-6-p-tolyl-1,2,4-triazine (25) [47]
were synthesized by known methods, other starting materials
were commercially available. Column chromatography was
performed on Merck silica gel 60. 1H and 13C NMR spectra
were recorded on a Bruker DRX-400 spectrometer; tetram-
ethylsilane (TMS) was used as an internal standard. Mass
spectra were recorded on a Bruker Daltonics MicroTOF-Q
II mass spectrometer with electrospray ionization.
General procedure for the synthesis of compounds 15–19a,
16b and 26–32
Method A. A mixture of 300 mg of triazine (1 eqv.),
anhydrous aluminum chloride (4 eqv.) and 3 mL of the
corresponding arene was stirred vigorously at room tem-
perature for 18 h. Then the reaction mixture was treated
with 10 mL of cooled water, and the water layer was de-
canted. The organic layer was evaporated, and the resulting
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residue was crystallized or chromatographed (see below for
details).
Method B. A mixture of 300 mg of triazine and anhydrous
aluminum chloride (4 eqv.) was refluxed in 3 mL of the cor-
responding arene for 1 h. For further work-up see method A.
6-Ph-5-(p-Tolyl)-4,5-dihydro-1,2,4-triazin-3(2H)-one (15a)
The substance was crystallized from an EtOAc-EtOH
mixture. M. p. 270 – 272 ◦C. – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.23 (s, 3 H, CH3), 5.66 (d, 1 H, J =
3.15 Hz, C(5)H), 7.13 (d, 2 H, J = 8.1 Hz, p-Tol), 7.19 (d,
2 H, J = 8.1 Hz, p-Tol), 7.30 – 7.37 (m, 3 H, Ph), 7.69 – 7.71
(m, 2 H, Ph), 7.98 (s, 1 H, NH), 10.23 ppm (d, 1 H, J =
1.9 Hz, NH). – 13C NMR (100 MHz, [D6]DMSO): δ = 21.1,
53.6, 126.1, 127.4, 129.0, 129.5, 129.9, 134.5, 137.8, 138.1,
143.8, 151.9 ppm. – HRMS ((+)-ESI): m/z = 266.1282
(calcd. 266.1288 for C16H16N3O, [M+H]+).
5,6-Di-(p-tolyl)-4,5-dihydro-1,2,4-triazin-3(2H)-one (16a)
The substance was crystallized from an EtOAc-EtOH
mixture. M. p. 260 – 261 ◦C. – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.28 (s, 3 H, CH3), 2.30 (s, 3 H, CH3),
5.50 (d, 1 H, J = 3.1 Hz, C(5)H), 7.08 – 7.10 (m, 4 H), 7.17
(d, 2 H, J = 8.0 Hz), 7.54 (d, 2 H, J = 8.1 Hz), 7.80 (s, 1
H, NH), 9.95 ppm (d, 1 H, J = 1.6 Hz, NH). – 13C NMR
(100 MHz, [D6]DMSO): δ = 21.1, 21.2, 53.6, 126.1, 127.3,
129.6, 129.9, 131.8, 137.8, 138.2, 139.2, 143.8, 152.0 ppm.
– HRMS ((+)-ESI): m/z = 280.1449 (calcd. 280.1444 for
C17H18N3O, [M+H]+).
5-(4-Bromophenyl)-6-(p-tolyl)-4,5-dihydro-1,2,4-triazin-
3(2H)-one (16b)
The substance was crystallized from an EtOAc-EtOH
mixture. M. p. 240 – 241 ◦C. – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.28 (s, 3 H, CH3), 5.68 (d, 1 H, J =
3.0 Hz, C(5)H), 7.16 (d, 2 H, J = 8.0 Hz), 7.22 – 7.42 (m,
4 H), 7.61 (d, 2 H, J = 8.1 Hz), 7.95 (s, 1 H, NH), 10.14 ppm
(s, 1 H, NH). – 13C NMR (100 MHz, [D6]DMSO): δ = 21.1,
54.3, 126.1, 127.4, 128.4, 129.3, 129.5, 132.0, 139.2, 141.1,
144.0, 151.9 ppm. – HRMS ((+)-ESI): m/z = 344.0389
(calcd. 344.0393 for C16H15BrN3O, [M+H]+).
6-(4-Bromophenyl)-5-(p-tolyl)-4,5-dihydro-1,2,4-triazin-
3(2H)-one (17a)
The substance was crystallized from an EtOAc-EtOH
mixture. M. p. 261 – 262 ◦C. – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.28 (s, 3 H, CH3), 5.54 (d, 1 H, J =
2.9 Hz, C(5)H), 7.09 (d, 2 H, J = 7.8 Hz), 7.17 (d, 2 H,
J = 7.9 Hz), 7.43 (d, 2 H, J = 8.5 Hz), 7.59 (d, 2 H, J =
8.5 Hz), 7.95 (s, 1 H, NH), 10.14 ppm (s, 1 H, NH). – 13C
NMR (100 MHz, [D6]DMSO): δ = 21.1, 53.5, 122.9, 127.3,
128.1, 130.0, 132.0, 133.7, 137.9, 138.0, 142.8, 151.6 ppm.
– HRMS ((+)-ESI): m/z = 344.0399 (calcd. 344.0393 for
C16H15BrN3O, [M+H]+).
5-(p-Tolyl)-5,6-diphenyl-4,5-dihydro-1,2,4-triazin-
3(2H)-one (18a)
The substance was crystallized from an EtOAc-EtOH
mixture. M. p. 261 – 262 ◦C. – 1H NMR (400 MHz,
[D6]DMSO): δ = 2.33 (s, 3 H, CH3), 7.01 – 7.21 (m, 9 H),
7.21 – 7.34 (m, 5 H), 8.31 (s, 1 H, NH), 10.21 ppm (s, 1
H, NH). – 13C NMR (100 MHz, [D6]DMSO): δ = 19.6,
66.1, 127.1, 127.8, 127.9, 128.2, 128.4, 128.5, 128.5, 128.6,
135.6, 137.9, 138.3, 141.5, 149.1, 154.1 ppm. – HRMS ((+)-
ESI): m/z = 342.1606 (calcd. 342.1601 for C22H20N3O,
[M+H]+).
5-(p-Tolyl)-5,6-diphenyl-4,5-dihydro-1,2,4-triazine-
3(2H)-thione (19a)
The substance was crystallized from EtOH. M. p.
239 – 240 ◦C. – 1H NMR (400 MHz, [D6]DMSO): δ = 2.33
(s, 3 H), 7.03 – 7.24 (m, 9 H), 7.24 – 7.35 (m, 5 H), 9.94
(d, 1 H, J = 1.4 Hz, NH), 11.54 ppm (d, 1 H, J = 1.5 Hz,
NH). – 13C NMR (100 MHz, [D6]DMSO): δ = 21.1, 64.6,
128.1, 128.5, 128.6, 129.0, 129.1, 129.2, 129.3, 135.5, 137.9,
138.3, 141.5, 148.5, 172.4 ppm. – HRMS ((+)-ESI): m/z =
358.1370 (calcd. 358.1372 for C22H20N3S, [M+H]+).
3-(Methylthio)-5-p-tolyl-1,2,4-triazine (26)
The substance was chromatographed with EtOAc-DCM
(1 : 1) as eluent. M. p. 146 – 148 ◦C. – Rf = 0.6. – 1H NMR
(400 MHz, CDCl3): δ = 2.44 (s, 3 H, CH3), 2.72 (s, 3 H,
SCH3), 7.34 (d, 2 H, J = 8.0 Hz, p-Tol), 8.05 (d, 2 H,
J = 8.2 Hz, p-Tol), 9.33 ppm (s, 1 H, NH). – 13C NMR
(100 MHz, [D6]DMSO): δ = 13.9, 21.7, 127.6, 130.1, 130.3,
141.8, 143.6, 154.5, 173.6 ppm. – HRMS ((+)-ESI): m/z =
218.0758 (calcd. 218.0746 for C11H12N3S, [M+H]+).
5-(4-Bromophenyl)-3-(methylthio)-4,5-dihydro-
1,2,4-triazine (27)
The substance was crystallized from a CH3CN-
(CH3)2CHOH mixture. M. p. 185 – 186 ◦C. – 1H NMR
(400 MHz, [D6]DMSO): δ = 2.76 (s, 3 H, SCH3), 5.43 (d,
1 H, J = 2.4 Hz, C(5)H), 7.36 (d, 2 H, J = 8.0 Hz), 7.56
(d, 1 H, J = 2.4 Hz), 7.68 (d, 2 H, J = 8.0 Hz), 12.94 ppm
(br.s, 1H). – 13C NMR (100 MHz, [D6]DMSO): δ = 13.7,
50.9, 122.2, 129.1, 132.0, 136.3, 144.4, 160.4 ppm. –
HRMS ((+)-ESI): m/z = 283.9846 (calcd. 283.9852 for
C10H11BrN3S, [M+H]+).
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5-(4-Bromophenyl)-3-Ph-4,5-dihydro-1,2,4-triazine (28)
The substance was crystallized from CH3CN. M. p.
185 – 186 ◦C. – 1H NMR (400 MHz, [D6]DMSO): δ = 5.63
(d, 1 H, J = 3.0 Hz, C(5)H), 7.47 (m, 2 H), 7.65 – 7.73
(m, 4 H), 7.79 – 7.83 (m, 1 H), 7.95 – 7.99 (m, 2 H), 12.16
(br.s, 1 H), 13.54 ppm (br.s, 1 H). – 13C NMR (100 MHz,
[D6]DMSO): δ = 50.3, 123.1, 125.0, 129.5, 129.6, 130.1,
132.7, 135.2, 137.3, 145.9, 154.6 ppm. – HRMS ((+)-
ESI): m/z = 314.0293 (calcd. 314.0287 for C15H13BrN3,
[M+H]+).
3-Me-5-Ph-5-(p-tolyl)-4,5-dihydro-1,2,4-triazine (29)
The substance was chromatographed with EtOAc-DCM
(1 : 1) as eluent. M. p. 130 – 131 ◦C. – Rf = 0.5. – 1H NMR
(400 MHz, [D6]DMSO): δ = 2.32 (s, 3 H, CH3), 2.44 (s,
3 H, CH3), 7.09 – 7.14 (m, 5 H), 7.23 – 7. ppm m, 5 H). –
13C NMR (100 MHz, [D6]DMSO): δ = 16.3, 21.1, 60.3,
127.3 (2C), 128.8, 129.0, 129.8, 137.7, 138.9, 140.7, 145.2,
154.8 ppm. – HRMS ((+)-ESI): m/z = 264.1495 (calcd.
264.1495 for C17H18N3, [M+H]+).
3,5,6-Triphenyl-5-(p-tolyl)-4,5-dihydro-1,2,4-triazine (30)
The substance was crystallized from EtOH. M. p.
185 – 186 ◦C. – 1H NMR (400 MHz, [D6]DMSO): δ = 2.35
(s, 3 H, CH3), 7.18 – 7.23 (m, 4 H), 7.28 – 7.42 (m, 9 H),
7.59 – 7.63 (m, 2 H), 7.74 – 7.78 (m, 1 H), 8.02 – 8.04 (m,
2 H), 12.23 (s, 1 H), 14.50 ppm (br.s, 1 H). – 13C NMR
(100 MHz, [D6]DMSO): δ = 21.1, 64.0, 128.5, 129.1, 129.4,
129.5, 129.8, 129.9, 130.5, 130.8, 133.8, 135.2, 135.3, 139.0,
153.3 ppm. – HRMS ((+)-ESI): m/z = 402.1956 (calcd.
402.1965 for C28H24N3, [M+H]+).
3-Methyl-5,6-diphenyl-5-(p-tolyl)-4,5-dihydro-1,2,4-triazine
(31)
The substance was crystallized from an EtOH-EtOAc
mixture. M. p. 236 ◦C. – 1H NMR (400 MHz, [D6]DMSO):
δ = 2.35 (s, 3 H), 2.44 (s, 3 H), 7.14 – 7.21 (m, 4 H),
7.25 – 7.29 (m, 5 H), 7.35 – 7.40 (m, 5 H), 12.42 ppm (s, 1
H). – 13C NMR (100 MHz, [D6]DMSO): δ = 16.1, 21.0,
63.5, 128.4, 129.0, 129.1, 129.2, 129.3, 129.7, 130.5, 134.1,
137.1, 138.9, 140.2, 150.6, 155.3 ppm. – HRMS ((+)-ESI):
m/z = 340.1795 (calcd. 340.1808 for C23H22N3, [M+H]+).
3-Phenyl-5,6-di(p-tolyl)-4,5-dihydro-1,2,4-triazine (32)
The substance was crystallized from a large amount of
acetone. M. p. 239 ◦C. – 1H NMR (400 MHz, [D6]DMSO):
δ = 2.31 (s, 3 H), 2.38 (s, 3 H), 6.19 (s, 1 H, C(5)H), 7.20
(d, 2 H, J = 7.8 Hz), 7.25 (d, 2 H, J = 8.0 Hz), 7.38 (d,
2 H, J = 7.8 Hz), 7.60 – 7.64 (m, 2 H), 7.74 – 7.78 (m, 1
H), 7.81 (d, 2 H, J = 8.0 Hz), 8.02 (d, 2 H, J = 7.8 Hz),
12.87 (br.s, 1 H, NH), 13.80 (br.s, 1 H, NH). – 13C NMR
(100 MHz, [D6]DMSO): δ = 20.6, 20.9, 49.4, 124.2, 127.0,
127.3, 128.8, 129.0, 129.2, 129.5, 129.9, 134.6, 134.6, 138.9,
141.9, 150.0, 152.4. – HRMS ((+)-ESI): m/z = 340.1811
(calcd. 340.1808 for C23H22N3, [M+H]+).
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